-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

904.O2.6 904. Outcomes Research – Non-Malignant Conditions: Across the Age Spectrum: Thromboembolism Outcomes in Adult and Pediatric Patients

Symposia: Outcomes Research—Non-Malignant Conditions Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Bleeding and Clotting, Research, Clinical Practice (Health Services and Quality), thromboembolism, Diseases, thrombotic disorders
Saturday, December 9, 2023: 9:30 AM-11:00 AM
Pacific Ballroom Salons 18-19 (Marriott Marquis San Diego Marina)
Ang Li, MD, MS, Baylor College of Medicine and Oluwatoyosi Onwuemene, MD, Duke University
Onwuemene: Sanofi: Honoraria.
This session includes abstracts that assess VTE in neonates, women ages 18-44 and all adults.
9:30 AM

Jiasen He, MD1,2, Natalie A Montanez1,3,4*, Stuart Fraser, MD1,4*, Audrey Barnett5,6*, Christin Silos, MS1,4*, Keely Smith, MD1,4* and Lakshmi Venkat Srivaths, MD1,3,4

1University of Texas Health Science Center at Houston, Houston, TX
2MD Anderson Cancer Center, Houston, TX
3Gulf States Hemophilia and Thrombophilia Center, Houston, TX
4UTHealth Institute for Stroke and Cerebrovascular Disease, Houston, TX
5Memorial Hermann Health System, Houston, TX
6Texas EMS, Acute Care, and Trauma Foundation (TETAF), Houston, TX

9:45 AM

Ummul Z Asfeen, DO1*, Kanishka Uttam Chandani, MD2*, Kalaivani Babu3*, Maithri Vallabhaneni, MBBS4*, Pratiksha Shankarlal Nathani, MBBS5*, Beenish Najam, MBBS6*, Sai Gautham Kanagala, MBBS7*, Srinishant Rajarajan, MBBS3*, Zainab Muslehuddin, MD8*, Taherunnisa Rida9*, Akhil Jain, MD10* and Rupak Desai, MBBS11*

1New York Medical College - Saint Michael's Medical Center, Harrison, NJ
2New York Medical College, Landmark Medical Center, Cumberland, RI
3Sri Ramachandra Medical College and Research Institute, Chennai, India
4Baton Rouge General Medical Center, Baton Rouge
5Vilasrao Deshmukh Government Medical College, Latur, India
6Karachi Medical and Dental College, Karachi, Pakistan
7Internal Medicine, Metropolitan Hospital Center, New York, NY
8Sinai Grace Hospital, Wayne State University, Detroit Medical Center, West Bloomfield, MI
9University Of Texas at Dallas, Richardson, TX
10Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
11Independent Researcher, Outcomes Research, Atlanta, GA

10:00 AM

Jordan K Schaefer, MD1, Josh Errickson, PhD2*, Xiaowen Kong, MA3*, Mona A Ali, PharmD4*, Naina Chipalkatti, MD5, Brian Haymart, RN, MS3*, Scott Kaatz, DO, MSc6*, Gregory D Krol, MD7*, Suman L Sood, MD, MSCE1, James Froehlich, MD, MPH3* and Geoffrey D. Barnes, MD, MSc3*

1Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI
2Consulting for Statistics, Computing, & Analytics Research, University of Michigan, Ann Arbor, MI, University of Michigan, Ann Arbor, MI
3Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI
4Department of Heart and Vascular Services, Corewell Health William Beaumont University Hospital, Royal Oak, MI
5Department of Internal Medicine, University of Michigan, Ann Arbor, MI
6Division of Hospital Medicine, Henry Ford Health, Detroit, MI
7Department of Internal Medicine, Henry Ford Health, Detroit, MI

10:15 AM

Josue Marquez1, Samantha Simon, BA2*, Jeffrey I. Zwicker, MD3, Brian Hollenbeck, MD2*, Robert Flaumenhaft, MD, PhD4 and Rushad Patell, MBBS5

1The Warren Alpert Medical School of Brown University, Providence, RI
2New England Baptist Hospital, Boston
3Memorial Sloan Kettering Cancer Center, New York, NY
4Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Boston, MA
5Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center, Boston, MA

10:30 AM

Andrew T. Kuykendall, MD1, Abdulraheem Yacoub, MD2, Nancy Reaven3*, Susan Funk3*, Pedro Oyuela, MD4*, Frank Valone, MD4*, Phil Dinh4*, Lucy Bellamy4*, Nikita Modi, PharmD4*, Arturo Molina, MD, MS, FACP4 and Suneel Gupta, PhD4

1Moffitt Cancer Center, Tampa, FL
2The University of Kansas, Westwood, KS
3Strategic Health Resources, La Canada, CA
4Protagonist Therapeutics, Inc., Newark, CA

10:45 AM

Justine Ryu, MD1, Jennifer La, PhD2*, Rushad Patell, MBBS3,4, Ang Li, MD, MS5, Nhan V Do, MD2,6*, Mary T Brophy, MD2,6*, Nathanael R Fillmore, PhD2,7,8* and Jeffrey I. Zwicker, MD9,10

1Section of Hematology, Yale University School of Medicine, New Haven, CT
2Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System, Boston, MA
3Division of Medical Oncology and Hematology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
4Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center, Boston, MA
5Section of Hematology-Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX
6Boston University School of Medicine, Boston, MA
7Harvard Medical School, Boston, MA
8Dana Farber Cancer Institute, Boston, MA
9Beth Israel Deaconess Medical Center Harvard Medical School, Boston, MA
10Department of Medicine, Weill Cornell Medical College, New York, NY

*signifies non-member of ASH